Clinical Trials Browser

Phase 2 × Interventional × Cardiovascular Diseases × Clear all

NCT05228470 2026-01-06

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Phase 2 Completed

39 enrolled 15 charts

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT06645691 2024-12-06

POLARIC-13

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

NCT04258683 2023-08-29

A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE

Phase 2 Withdrawn

Cardiovascular Diseases, Hematologic Diseases, Immune System Diseases, Multiple Myeloma, Neoplasms

NCT03785704 2020-01-22

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Cardiovascular Diseases

NCT04182594 2019-12-02

Cardiovascular Events in GnRH Agonist vs. Antagonist

Phase 2 Unknown

Cardiovascular Diseases, Prostatic Neoplasms

NCT01733953 2016-12-14

Statin Therapy in Young Adult Survivors of Childhood Cancer

Phase 2 Completed

27 enrolled 11 charts

LymphoidOther hematologic neoplasm

Cardiovascular Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00006181 2014-01-07

PHLAME

Phase 2 Completed

Cardiovascular Diseases, Motor Activity, Neoplasms

NCT00010829 2006-08-18

Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Osteoporosis, Endometrial Neoplasms